1140
O. D. Mitkin et al.
PAPER
2-(4-[1,3]Dithian-5-yl-phenoxy)-6-methoxymethyl-3,4,5-
Bidentate Precursor 19; Typical Procedure
A solution of 1 (1.2 g, 5.35 mmol) in freshly distilled THF (20 mL)
was cooled to –78 °C under N2. Then n-BuLi (1.6 M solution in
hexanes, 5.76 mmol, 3.6 mL) was added drop-wise with stirring.
The resulting mixture was allowed to stand for 2 h at –20 °C. Then
5,17-diformyl-25,26,27,28-tetrakis(2-ethoxyethoxy)calix[4]arene5
(0.62 g, 0.8 mmol) was added and the reaction mixture was stirred
overnight at r.t. The reaction mixture was quenched with sat.
NH4Cl, evaporated, and extracted with CHCl3. The solvent was re-
moved under reduced pressure and the residue was purified by col-
umn chromatography (EtOAc–hexane, 2:3) to afford 0.484 g of 19
(49.7%).
trimethoxy-tetrahydropyran (28)
To a stirred solution of 2,3,4,6-tetra-O-methyl-D-glucopyranose
2612 (400 mg, 1.69 mmol) and 4-[1,3]dithian-5-yl-phenol (27, 358
mg, 1.69 mmol) in THF (6 mL) at 0 °C were added Ph3P (443mg,
1.69 mmol) and a solution of diethyl azodicarboxylate (294 mg,
1.69 mmol) in THF (3 mL). The mixture was stirred at r.t. over-
night. It was concentrated and the product was isolated by column
chromatography to afford 28 (510 mg, 70%).
1H NMR (CDCl3): = 7.09 (d, 2H, J = 8 Hz), 6.97 (d, 2H, J = 8
Hz), 4.80 (d, 1H, J = 7 Hz), 4.09 (d, 1H, J = 14 Hz), 3.67–3.64 (m,
1H), 3.65 (s, 3H), 3.64 (s, 3H), 3.59–3.55 (m, 1H), 3.55 (s, 3H),
3.49–3.39 (m, 2H), 3.38 (s, 3H), 3.30–3.20 (m, 3H), 3.16–3.08 (m,
1H), 3.05–2.95 (m, 2H), 2.82–2.75 (m, 2H).
Calixarenic Bidentate Precursor 19
1H NMR (CDCl3) = 6.29–6.86 (m, 10H), 4.46–4.52 (m, 4H),
4.34–4.39 (m, 2H), 4.18–4.21 (m, 4H), 4.00–4.07 (m, 4H), 3.78–
3.89 (m, 10H), 3.63 (s, 2H), 3.49–3.58 (m, 8H), 2.67–3.17 (m,
20H), 2.04 (s, 2H), 1.14–1.23 (m, 12H).
13C NMR (CDCl3): = 156.1, 139.2, 127.4, 116.8, 101.2, 86.2,
83.3, 79.0, 74.7, 71.1, 60.9, 60.5, 60.4, 59.3, 43.1. 35.9, 35.8, 31.1.
Adduct of 28 with Benzaldehyde; Compound 30
Anal. Calcd for C60H80O10S8: C, 59.18; H, 6.62. Found: C, 58.77; H,
6.84.
A solution of glycoside 28 (190 mg, 0.44 mmol), n-BuLi (1.6 M so-
lution in hexanes, 0.71 mmol, 0.44 mL), and benzaldehyde (75 mg,
0.71 mmol) was reacted as described above for 21. The product was
purified by column chromatrography. (76 mg, 32%).
1H NMR (CDCl3): = 7.46–7.32 (m, 5H), 7.07 (d, 2H, J = 8 Hz),
6.95 (d, 2H, J = 8 Hz), 4.91 (dd, 1H, J = 4, 7 Hz), 4.77 (d, 1H,
J = 6 Hz), 4.48 (d, 1H, J = 6 Hz), 3.65–3.63 (m, 1H), 3.64 (s, 3H),
3.63 (s, 3H), 3.58–3.54 (m, 1H), 3.54 (s, 3H), 3.40–3.37 (m, 1H),
3.37 (s, 3H), 3.28–3.18 (m, 3H), 3.07–2.94 (m, 3H), 2.90–2.80 (m,
2H), 2.72 (d, 1H, J = 4 Hz).
Dibenzo-24-crown-8 based Bidentate Precursor 18
1H NMR (CDCl3) = 6.79–6.96 (m, 6H), 4.74–4.79 (m, 2H), 4.11–
4.28 (m, 8H), 4.00 (d, 2H, J = 7.3 Hz), 3.86–3.90 (m, 8H), 3.79–
3.82 (m, 8H), 3.64 (s, 4H), 2.73–3.09 (m, 16H), 2.00 (s, 2H).
Dibenzo-18-crown-6 based Bidentate Precursor 17
1H NMR (DMSO-d6) = 6.82–6.95 (m, 6H), 4.63 (d, 2H), 4.18 (d,
2H), 4.01–4.07 (m, 8H), 3.79–3.85 (m, 8H), 3.70 (s, 4H), 2.67–3.10
(m, 16H).
13C NMR (CDCl3): = 156.2, 139.9, 138.4, 128.4, 128.2, 127.5,
126.3, 116.9, 101.3, 86.3, 83.4, 79.1, 75.8, 74.8, 71.2, 60.9, 60.6,
60.5, 59.4, 54.9, 42.6, 36.6, 36.2.
Adduct of 23 with Benzaldehyde; Compound 31
A solution of 23 (287 mg, 0.79 mmol), n-BuLi (1.6 M solution in
hexanes, 1.3 mmol, 0.79 mL), and benzaldehyde (134 mg, 1.3
mmol) was reacted as described above for 21. Purification by col-
umn chromatography produced diastereomers 31 (160 mg, 43%).
HRMS: m/z calcd for C27H35O6S2 [MH – H2O]+: 519.1875. Found:
519.1856.
Adduct of 29 with Dithiane; Compound 32
A solution of 1,3-dithiane (100 mg, 0.83 mmol) in THF (15 mL)
was cooled to –25 °C under N2. Then n-BuLi (1.6 M solution in
hexanes, 1.0 mmol, 0.63 mL) was added drop-wise with stirring.
The resulting mixture was stirred for 2 h at –25 °C. It was then add-
ed slowly into a solution of 4-O-[tetra-O-acetyl- -D-glucopyrano-
syl]benzaldehyde 2913 (377 mg, 0.83 mmol) in THF (20 mL) at
–78 °C with vigorous stirring. The reaction mixture was stirred for
1 h at this temperature and then stored in a freezer at –25 °C over-
night. The work-up procedure was the same as for 21. The product
was purified by column chromatography (250 mg, 52%).
1H NMR (CDCl3): = 7.35 (d, 2H, J = 9 Hz), 6.98 (d, 2H, J = 9
Hz), 5.32–5.23 (m, 2H), 5.16 (m, 1H), 5.09 (dd, 1H, J = 3, 6 Hz),
4.88 (d, 1H, J = 6 Hz), 4.27 (dd, 1H, J = 6, 12 Hz), 4.16 (d, 1H,
J = 12 Hz), 4.04 (dd, 1H, J = 3, 8 Hz), 3.89–3.82 (m, 1H), 3.02–
2.88 (m, 2H), 2.78–2.68 (m, 2H), 2.05–1.95 (m, 2H), 2.08 (s, 3H),
2.051 (s, 3H), 2.046 (s, 3H), 2.03 (s, 3H).
Diastereomers 31a
1H NMR (CDCl3): = 7.41–7.29 (m, 5H), 5.00 and 4.99 (two s,
1H), 4.86 (dd, 1H, J = 3, 8 Hz), 4.78 (d, 1H, J = 6 Hz), 4.52 (d, 1H,
J = 6 Hz), 4.56–4.39 (m, 1H), 4.36 (d, 1H, J = 8 Hz), 4.33–4.27 (m,
1H), 4.11 (d, 1H, J = 8 Hz), 4.02 and 4.00 (two d, 1H, J = 7 Hz),
3.41 (dd, 2H, J = 8, 12 Hz), 3.33 and 3.32 (two s, 3H), 3.20 (dd, 1H,
J = 3, 15 Hz), 3.00 (dd, 1H, J = 3, 7 Hz), 2.93 (d, 1H, J = 15 Hz),
2.43 (dd, 1H, J = 4, 14 Hz), 2.31 (dd, 1H, J = 8, 14 Hz), 1.48 (s,
3H), 1.31 (s, 3 H).
13C NMR (CDCl3): = 139.8, 128.4, 128.2, 126.69, 126.66,
112.57, 112.56, 109.0, 108.9, 101.2, 86.84, 86.80, 84.7, 80.9, 74.5,
74.4, 73.1, 73.0, 72.9, 54.73, 54.70, 53.0, 52.8, 32.5, 32.3, 31.9,
31.8, 28.7, 26.5, 25.2.
Diastereomers 31b
1H NMR (CDCl3): = 7.42–7.30 (m, 5H), 4.991 and 4.985 (two s,
1H), 4.89 (dd, 1H, J = 3, 7 Hz), 4.80–4.76 (m, 1H), 4.52 (d, 1H,
J = 6 Hz), 4.50–4.45 (m, 1H), 4.36 (d, 1H, J = 7 Hz), 4.28–4.23 (m,
1H), 4.10–4.03 (m, 2H), 3.47 (d, 1H, J = 12 Hz), 3.40 (d, 1H,
J = 12 Hz), 3.334 and 3.325 (two s, 3H), 3.20 (dd, 1H, J = 4, 14
Hz), 2.90 (d, 1H, J = 14 Hz), 2.84 (dd, 1H, J = 3, 7 Hz), 2.50 (dd,
1H, J = 6, 14 Hz), 2.30 (dd, 1H, J = 6, 14 Hz), 1.47 (s, 3H), 1.31
and 1.30 (two s, 3H).
13C NMR (CDCl3): = 170.3, 170.0, 169.1, 169.0, 156.6, 134.9,
128.0, 116.53, 116.50, 98.9, 98.8, 74.13, 74.07, 72.7, 72.1, 71.1,
68.3, 62.0, 52.9, 28.3, 27.7, 25.4, 20.84, 20.78, 20.74, 20.72.
HRMS: m/z calcd for C25H33O11S2 [MH+] 573.1464. Found:
573.1441.
Monoadduct of 1 with 4-Formyldibenzo-24-crown-8;
Compound 15
13C NMR (CDCl3): = 139.8, 128.4, 128.2, 126.64, 126.59, 112.6,
109.00, 108.97, 101.28, 101.25, 86.84, 86.82, 84.8, 80.94, 80.93,
74.7, 74.6, 73.7, 73.6, 72.5, 72.4, 54.8, 54.7, 53.4, 53.2, 33.0, 32.9,
32.0, 31.8, 28.7, 26.6, 25.2.
HRMS: m/z calcd for C22H29O6S2 [MH – H2O]+: 453.1406. Found:
453.1406.
A solution of 1 (611 mg, 2.73 mmol) in THF (50 mL) was treated
with n-BuLi (1.6 M solution in hexanes, 3.27 mmol, 2.04 mL) and
reacted with 4-formyldibenzo-24-crown-814 (1 g, 2.1 mmol in 25
mL of THF) as described above for 21. The reaction mixture was
quenched with sat. NH4Cl and extracted twice with Et2O (2 10
Synthesis 2001, No. 8, 1133–1142 ISSN 0039-7881 © Thieme Stuttgart · New York